What Pharmaceutical Formulators Need to Know Before Switching
Glycine is glycine, whether the carbon backbone originated from a fossil-derived or renewable-derived feedstock. For pharmaceutical formulators, the real question when a bio-based option appears on the market is not whether it performs differently, it does not, but whether the sourcing story and documentation package meet what a regulatory filing and a sustainability commitment both require.
USP monograph compliance: assay range, heavy metals, loss on drying, and pH specifications
Functional role as a buffering agent and excipient in freeze-dried and injectable formulations
Physical and chemical behavior once incorporated into a formulation
Feedstock origin documentation, renewable versus conventional
Supply chain traceability requirements tied to that origin claim
Sustainability reporting eligibility for the finished drug product's own ESG disclosures
Both grades are manufactured at Avid Organics' Vadodara facility to meet pharmaceutical-grade documentation standards. AviGly™ Bio HP is the renewable-origin option, positioned specifically for APIs, excipients, and critical formulations where a bio-based sourcing claim adds value to the finished product, without changing the pharmacopeial standard the material is held to.
Confirm both grades reference the same pharmacopeial standard on their Certificate of Analysis
Request side-by-side batch data if running a formal formulation comparability study
Check whether your existing regulatory filing references a specific grade by name that would need updating as part of the switch
Avid Organics has produced pharmaceutical and cosmetic grade glycine for over 19 years, with more than 2,400 MT of annual glycine capacity at its ISO-certified Vadodara facility.
Compare AviGly™ HP and AviGly™ Bio HP specifications, or request documentation for a formulation comparability study, at avidorganics.net/en/product/amino-acids
No. It is chemically identical to conventional USP glycine and follows the same pharmacopeial compliance path.
It depends on how your existing filing references the excipient source. Check with your regulatory affairs team directly, though the underlying pharmacopeial standard itself does not change.
Sourcing and process differences can affect pricing. Request a quote for both grades directly to compare for your specific volume and application.
A USP-referenced Certificate of Analysis, renewable-origin sourcing documentation, and standard regulatory filing support from Avid Organics.
Yes. Both are produced at the same certified Vadodara facility under the same quality management system.
